Olaf Kniemeyer

Title: The Innovations of Olaf Kniemeyer

Introduction

Olaf Kniemeyer is a notable inventor based in Jena, Germany. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the selective activation and analysis of specific CD4 T cells, which are crucial for understanding immune responses.

Latest Patents

Kniemeyer holds a patent that provides an in-vitro method for the use of at least one in-vivo-target antigen for the selective activation, detection, and analysis of specific CD4 T cells in a sample. This invention reveals an immune reactivity characterized by the presence of antigen-specific T cells, which include a high percentage of memory T cells. The patent outlines that these antigen-specific T cells can produce IFN-gamma and IL-17 upon stimulation, with specified frequencies. The antigens involved in this patent may include Scw4, Pst1, Shm2, GliT, and TpiA, or their fragments. Additionally, the patent includes a method, a composition, and a kit for practical applications.

Career Highlights

Throughout his career, Kniemeyer has worked with prominent organizations such as Miltenyi Biotec GmbH and the Leibniz Institute for Natural Product Research and Infection Biology—Hans Knoll Institute. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Kniemeyer has collaborated with notable colleagues, including Alexander Scheffold and Petra Bacher. These partnerships have enhanced his research and expanded the impact of his innovations in immunology.

Conclusion

Olaf Kniemeyer is a distinguished inventor whose work in immunology has led to significant advancements in the understanding of T cell activation and analysis. His contributions through patents and collaborations continue to influence the field positively.